Biovica

Biovica is a bio-diagnostic company founded in 2009 and based on research from Uppsala University. Biovica’s innovative technology, the DiviTum™ assay, measures the rate of cell proliferation to determine tumor aggressiveness and growth rate.

Biovica aims to contribute to personalized healthcare, to improve outcomes for cancer patients, and to increase success rates for pharmaceutical companies in drug development.

The fundamental questions of treating cancer are:

  • Can we identify and predict which patients will respond to therapy?
  • How can we best determine whether the tumor is growing or not?
  • How can we improve the ability to monitor the efficacy of cancer therapies?

Biovica is diligently working to answer these questions with clinicians and pharmaceutical companies worldwide.

Kategorier: Diagnostics

Gå till Biovicas hemsida